Clinical Trial Update: A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Enlicitide Chloride (MK-0616) in healthy participants and those on statins (MK-0616-012); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Enlicitide Chloride (MK-0616)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Healthy, Hypercholesterolemia | Phase 1 | Status: COMPLETED